Raczak G, Swiatecka G, Lubinski A, Kubica J
Cardiological Department of IIIrd Internal Clinic, Medical Acadamy of Gdansk, Poland.
Pacing Clin Electrophysiol. 1990 Dec;13(12 Pt 2):2048-53. doi: 10.1111/j.1540-8159.1990.tb06940.x.
The clinical effects of transesophageal atrial pacing (TAP) were assessed in 308 patients. Indications for TAP included evaluation for pacemaker implantation in patients suspected of sinus node dysfunction and determination of the suitable type of pacemaker. Most patients underwent program stimulation including rapid as well as burst stimulation. In one patient, following the study, cerebral arterial embolism occurred, most likely secondary to an induced arrhythmia. That was the only single case of permanent consequences following TAP. Additionally, one patient was accidentally stimulated in the ventricle using low voltage electric current that induced ventricular fibrillation. This was promptly reversed with defibrillation. Twenty-six patients in whom an arrhythmia was previously induced, required medical therapy, two of whom required cardioversion, and 24 required drug therapy, subsequent to clinical intolerance of the arrhythmia. No lethal complications occurred.
对308例患者评估了经食管心房起搏（TAP）的临床效果。TAP的适应证包括对疑似窦房结功能障碍患者进行起搏器植入评估以及确定合适的起搏器类型。大多数患者接受了程控刺激，包括快速刺激和猝发刺激。1例患者在研究后发生脑动脉栓塞，很可能继发于诱发性心律失常。这是TAP后唯一出现永久性后果的单一病例。此外，1例患者使用低电压电流意外刺激心室，诱发了心室颤动。通过除颤迅速恢复正常。26例曾诱发心律失常的患者需要药物治疗，其中2例需要心脏复律，24例在心律失常出现临床不耐受后需要药物治疗。未发生致命并发症。
